Significant Revenue Growth
BIO-key's Q2 2025 revenue increased by 49% to $1.7 million compared to $1.1 million in Q2 2024, with improvements in each segment.
Expense Reduction Achievements
SG&A expenses were trimmed by 13.5% versus last year, more than offsetting increased investments in R&D.
International Defense Contracts
Secured major contracts including a deployment with the National Bank of Mozambique and a 3-year PortalGuard deployment with a Middle East police force.
Expanded Market Opportunities
Improved traction in EMEA regions with a focus on BIO-key branded solutions, leading to positive year-over-year revenue comparisons.
Strong Gross Margins
Despite a decline, gross profit increased by 40% to $1.2 million due to increased total revenue, maintaining a strong gross margin of 73% in Q2 2025.